How can patients and providers best contribute to the HTA process?

•

2 likes•980 views

How can patients and providers best contribute to the HTA process? Anna Nachtnebel, LBI-HTA, Simone Warren, ZIN Presentation from the 3rd face to face training course for EUnetHTA Stakeholders organised by EUnetHTA JA2 WP2; April 23rd, 2015, Brussels.

Health & Medicine

European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu
How can patients and providers
best contribute to
the HTA process
Sime Warren, National Health Care Institute of the Netherlands, Diemen, the Netherlands
Anna Nachtnebel, Ludwig Boltzmann Institute for HTA, Vienna, Austria
WP5 - Applying the HTA Core Model for Rapid Assessment for national adaptation and
reporting
Third WP2 Face to Face Training Course for EUnetHTA stakeholders, Brussels, 23rd of April
2015

European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.euEuropean network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu
Stakeholder involvement
Strand A and Strand B
2

Stakeholder Involvement Strand A
Close
collaboration
with the
participating
manufacturer
Update of the
HTA Core Model
application for
REAs 
Stakeholder and
public
consultation
Feedback session with
manufacturer about the
draft submission
template (WP7)

May 8, 2015European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu 4
Stakeholder Involvement Strand B

European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu
Compilation of final project plan
 Stakeholder Advisory Group & Stakeholder Forum: informed about
upcoming public consultation of project plan, inquiry to suggest external
medical experts, patients representatives, identification of manufacturers
 Manufacturer(s): informed about upcoming public consultation of project
plan, to submit evidence/information on reimbursement status, submission
file, scoping meeting(?)
 Patients: scoping - selection of relevant outcomes, comparators, draft
project plan
 Medical experts: scoping - selection of relevant outcomes, comparators,
draft project plan
 Public: draft project plan
Stakeholder involvement - Scoping Phase

European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu
Production of final assessment
Manufacturer(s), patients, medical experts: opportunity
to comment on second draft of assessment, comments &
answers publicly available
Further involvement
Update of HTA Core Model for Rapid REA
Stakeholder involvement - Assessment Phase
6

European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu
1. Where do you think stakeholder involvement is
most relevant?
2. Could you think of other ways of stakeholder
involvement?
Plenary session Strand A and Strand B
7

European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu
Thank you!
This presentation arises from the EUnetHTA
Joint Action 2 which has received funding
from the European Union, in the framework of
the Health Programme

The document discusses the development of a submission template by the EUnetHTA to support health technology assessments and reimbursement decisions across European countries. It describes analyzing evidence requirements from 33 countries to identify common information requests. Based on this, a draft template was created addressing key domains like the health problem, technology description, clinical effectiveness and safety. The template categories information under common themes and is being piloted and validated before dissemination. It aims to streamline the process of providing evidence to support assessments and reimbursement while allowing flexibility for country-specific needs.

How to use HTA for decision-making based on HTA Core Information

EUnetHTA

The HTA Core Model® A brief introduction

EUnetHTA

EUnetHTA Training course for Stakeholders - How to use HTA for decision makin...

EUnetHTA

EUnetHTA Training course for Stakeholders - Introduction to the HTA Core Mode...

EUnetHTA

The document discusses the HTA Core Model, which is a framework developed by EUnetHTA to standardize and share health technology assessment information. The key goals of the Core Model are to capture the core elements of HTA that can be shared, enable production of structured HTA information, support joint and local HTA production. The Core Model consists of HTA questions/ontology, methodological guidance, and a reporting structure. It provides a standardized way to organize and report HTA information on a health technology.

Brief introduction to EUnetHTA and its tools

EUnetHTA

The document summarizes the history and objectives of the European network for Health Technology Assessment (EUnetHTA). It began in 2004 when the European Commission recognized the need to establish a sustainable HTA network. This led to the EUnetHTA project in 2006-2008 and subsequent collaborations. The current joint action, EUnetHTA JA2 from 2012-2015, aims to strengthen practical HTA collaboration across Europe and make recommendations for a permanent HTA network. It involves partners from various countries working on HTA tools, reports, and increasing cooperation between stakeholders like HTA agencies and the EMA.

Cadth 2015 d2 warren cadth april_14_2015

CADTH Symposium

This document summarizes the work of the EUnetHTA network in developing tools and processes for conducting rapid relative effectiveness assessments of health technologies collaboratively across countries. It describes the HTA Core Model, which provides a standardized framework. It also outlines the process used for the joint rapid assessments conducted by Work Package 5, including assembling multinational authoring teams, developing assessment plans, collecting evidence from manufacturers, and producing summaries. Challenges in applying this process to medical devices are discussed along with some proposed solutions.

1st eStandards conference: next steps for standardization in large scale eHea...

chronaki

eStandards conference: Next steps for standardization in large scale eHealth ...

chronaki

This document provides an introduction and agenda for the First eStandards Conference. The conference will discuss shaping a culture of high eStandards to support large-scale eHealth deployment across Europe. Four key challenges of large-scale eHealth will be examined: understanding healthcare specifics, connecting within and outside the health system, advancing digital innovation, and documenting best practices. The case for standardization to realize visions like engaged citizens and knowledge dissemination will be made. Collaboration across stakeholders like healthcare, technology, workforce and citizens is needed. Key questions to be discussed are the drivers for large-scale eHealth deployment, essential standards to enable safe and cost-effective implementation, and actions for standards development organizations and policymakers.

Health Technology Assessment : Interpreting a HTA report

Pharmacy @ Institut Kanser Negara

The document provides an overview of health technology assessment (HTA) reports produced by the Malaysian Health Technology Assessment Section (MaHTAS). It discusses MaHTAS's functions, products, and processes for conducting HTAs. Key points include that MaHTAS has produced over 550 HTA reports since 1997 covering various health technologies. The document also outlines criteria for evaluating the quality of HTA reports based on a checklist from the International Network of Agencies for HTA, focusing on transparency around methods, sources of information, and conclusions.

Health Technology Assessment (HTA): a tool for evidence-informed decision mak...

WHO Regional Office for the Eastern Mediterranean

This document provides an overview of health technology assessment (HTA) through a presentation given at the 62nd Session of the WHO Regional Committee for the Eastern Mediterranean. It defines HTA and its goals of providing evidence-informed input to decision makers and ensuring value for money. The presentation outlines how HTA is a multidisciplinary activity that examines the effects of health technologies on resources, costs, technical aspects, and other issues. It provides examples of HTA implementation from Thailand, Iran, and other countries. The presentation calls for all countries to establish national HTA programs and capacities and emphasizes that HTA is especially important for resource-limited settings. It outlines future commitments and steps from member states and WHO to strengthen HTA in the

1st eStandards conference: next steps for standardization in large scale eHea...

chronaki

Evaluating Health Technology Assessment Reports and New Assessment Techniques...

bpstat

2nd Annual Health Outcomes and Pharmacoeconomics Research Conference • Setting up internal processes to ensure proper Health Technology Assessment (HTA) • Exploring initiatives to translate reported outcomes to ensure proper understanding of data • Assessing the key HTA entities in the U.S. and establishing assessment protocol • Differentiating HTA strategies with new technology assessment strategies to improve assessment processes

Présentation d'Alain Bravo à la journée "Questions numériques 2011"

Fing

The document summarizes the key findings and recommendations from a panel that evaluated the FP7-ICT program. The panel found the ICT program to be relevant and well-implemented, but made recommendations in three areas: 1) Strengthening European ICT research globally by continuing the ICT theme and building partnerships. 2) Exploiting ICT's influence across sectors through coordinated policies and involvement of users/industry. 3) Sharing risks more to increase participation, especially of SMEs, through simplified rules and a two-stage application process.

Governance in DRIVE - Laurence Torcel-Paignon Sanofi Pasteur

DRIVE research

The document describes the governance structure of the DRIVE project, which aims to generate brand-specific influenza vaccine effectiveness estimates in Europe. It establishes separate bodies for independent scientific oversight (Independent Scientific Committee), quality control and auditing (Quality Control and Audit Committee), and joint decision-making between public and private partners (Steering Committee). Work Package 7, conducted by public health institutes, is responsible for developing and implementing studies to determine vaccine effectiveness, while ensuring independence from vaccine manufacturers. The governance structure is evaluated yearly and adapted as needed based on insights and stakeholder feedback.

Building a Community of Practice for people in charge of HTA dissemination

Patrice Chalon

Presentation at the 12th Annual Meeting of the HTAi (Oslo, Norway, June 15-17th, 2015). Background EUnetHTA, the European network for Health Technology Assessment has for about a decade comprehensively dealt with various HTA production aspects. However, dissemination of the final HTA report was yet to be addressed. In order to identify best practices in this field, a Community of Practice (CoP) was initiated with the aim of bringing together people in charge of HTA dissemination amongst EUnetHTA members. Objectives To describe the building process and first results of the EUnetHTA Community of Practice on dissemination. Methods The objective of the CoP was defined by a work-team. Potential participants were identified from all EUnetHTA Partners, and as a first step a webinar was organised to present interested participants with the concept and objective of the CoP. Subsequently, a workshop was organised to share knowledge and plan future activities. Results 44 people from 25 agencies in 18 countries joined the CoP. Of these, 25 participated in the webinar and confirmed the utility of the CoP. The workshop brought together 17 people and resulted in identification of crucial steps in the HTA dissemination process, knowledge exchange about dissemination actions, and main topics of interest to the CoP. A series of Webinars provided by the CoP members themselves has been set up, two webinars has already been conducted, and a third is planned later this year. Conclusion The CoP provides a suited format for formally exchanging information about dissemination of HTA reports and establishing best practices together with peers. Best practices identified through the workshop and the webinars will be compiled in a best practice document. Further activities will be planned in the future, including the consideration of stakeholder involvement.

Connected health data meets the people: Diversity, Standards, and Trust

chronaki

Using health data in a connected world requires new competencies, a personal digital health compass calibrated to individual personalities and needs. Patients and clinicians able to collect and manage data, data-operational informatics professionals able to analyze data, and cutting-edge researchers, innovators, and educators able to apply knowledge, will take learning health systems to the next level. In this EFMI-HL7 event using innovative technology and surprises to engage the audience, we will discuss strategies for empowering and activating people to engage, share and use their health data. We will point to diversity, trust and open standards like HL7 FHIR to open up access and capacities to manage data safely for patients, care-givers, and the health system. The Maturing Telemedicine Infrastructure in Denmark: Building the Human Capital, Morten Bruun-Rasmussen, CEO MEDIQ Health Professional Education in Biomedical & Health Informatics: the EFMI AC2 approach, Professor John Mantas, University of Athens, Greece, EFMI Past President Digital health literacy: a necessity for Activating Citizens, Professor Anne Moen, University of Oslo, Norway, VP for IMIA, European Federation for Medical Informatics “Internet of People”: Elements of Trust and Risk, Eva Turk, DNVGL. Workforce meets volumes of electronic information: Why and how HL7 FHIR creates value for stakeholders in learning health systems. Doug Fridsma, President and CEO, American Medical Informatics Association, US

European study on Monitoring e-accessibility 2009-2011

Jose Angel Martinez Usero

The document summarizes a study on monitoring eAccessibility in Europe. The study aims to monitor progress on eAccessibility in selected European and non-European countries, identify best practices, and develop annual reports and a benchmarking framework. It involves surveys of national experts on technologies and policies, and consultation with stakeholders. The main outcomes will include a website, data analysis tools, and reports on various accessibility topics.

Commission studies on eaccessibility

Jose Angel Martinez Usero

This document summarizes two studies conducted by the European Commission (EC) on eAccessibility. The first study monitored the status and progress of eAccessibility in 12 EU countries and 3 non-EU countries. It analyzed surveys from national experts, technology experts, and policy experts. The study produced annual reports, a website with benchmarking tools, and reports on transposition of accessibility directives. The second study assessed the economic impacts of improving eAccessibility for web content, digital TV, ATMs and other technologies. It developed a cost-benefit analysis tool for organizations and estimated aggregate economic benefits and costs. The study provided recommendations to policymakers and involved member states in validating outcomes.

Horizon 2020 Proposal evaluation

Agència per a la Competitivitat de l'empresa - ACCIÓ

This document provides an overview of the Horizon 2020 proposal evaluation process. It describes the key steps, including: 1) Individual evaluation of proposals by remote evaluators against evaluation criteria of excellence, impact, and quality of implementation. 2) A consensus group discussion to agree on comments and scores. If an applicant lacks operational capacity, their part is excluded. 3) A panel review to ensure consistency and prioritize proposals. Proposals are ranked based on scores and consideration of topics not already covered. 4) An ethics review of proposals that pass thresholds to ensure compliance with ethical standards.

Innovative medical technologies

KTN

The Office for Life Sciences (OLS) in partnership with Innovate UK is working to support developers of innovative medical devices, diagnostics and regulated digital health products to evaluate their products in a real-world clinical setting. Funding is being made available through a series of competitions that will run over the next 2 years. The first round of the competition was run in early 2018. The second round of the competition ‘Support for SMEs to evaluate innovative medical technologies competition’ opened on 2 July. Up to £1.5m funding is available to support small and medium-sized enterprises (SMEs) generate an evidence base that will enable the evaluation of products that address priorities areas for NHS England. This support is intended to allow companies to collect and analyse clinical performance and cost effectiveness data within an NHS setting. Watch the webcast via KTN's YouTube channel: https://www.youtube.com/c/KnowledgeTransferNetwork

Insights into the Canadian eHealth Landscape - MaRS Future of Medicine

MaRS Discovery District

In recognition of the need to develop a national digital health strategy and to co-ordinate activity across the country, the Conference of Deputy Ministers established Canada Health Infoway in 2001. This lecture describes Infoway’s role and the progress that it and its jurisdictional partners have made over the last decade. It outlines the challenges to achieving our collective goal of using technology to improve the health of Canadians and describes key enablers that must be in place for us to be successful. It also contains the results of recent public opinion research conducted with Canadians and healthcare providers and outlines the priorities for moving forward and the opportunities for action.

4 Pillars of High Impact Leadership

Jennifer McClure

Manage Stakeholder Relations

Info-Tech Research Group

Make proper stakeholder management a habit. Learn more at http://www.infotech.com/research/ss/manage-stakeholder-relations. As a CIO, you are responsible for addressing a wide variety of competing demands of many different stakeholders. Stakeholders can be difficult to identify; it is often these hidden stakeholders that can unexpectedly derail your agenda. Understanding which of your stakeholders are most important and determining the best way to address the needs of each one can be complex and time consuming.

What's hot

EUnetHTA Training course for Stakeholders - Choice of Endpoints forReimburse...

EUnetHTA

EUnetHTA Training course for Stakeholders - Key principles of Health Technolo...

EUnetHTA

EUnetHTA Training course for Stakeholders - Brief introduction to EUnetHTA an...

EUnetHTA

EUnetHTA Training course for Stakeholders - Brief introduction to EUnetHTA

EUnetHTA

Cadth 2015 d2 warren cadth april_14_2015

CADTH Symposium

1st eStandards conference: next steps for standardization in large scale eHea...

chronaki

eStandards conference: Next steps for standardization in large scale eHealth ...

chronaki

Health Technology Assessment : Interpreting a HTA report

Pharmacy @ Institut Kanser Negara

Health Technology Assessment (HTA): a tool for evidence-informed decision mak...

WHO Regional Office for the Eastern Mediterranean

1st eStandards conference: next steps for standardization in large scale eHea...

chronaki

Evaluating Health Technology Assessment Reports and New Assessment Techniques...

bpstat

Présentation d'Alain Bravo à la journée "Questions numériques 2011"

Fing

Governance in DRIVE - Laurence Torcel-Paignon Sanofi Pasteur

DRIVE research

Building a Community of Practice for people in charge of HTA dissemination

Patrice Chalon

Connected health data meets the people: Diversity, Standards, and Trust

chronaki

European study on Monitoring e-accessibility 2009-2011

Jose Angel Martinez Usero

Commission studies on eaccessibility

Jose Angel Martinez Usero

Horizon 2020 Proposal evaluation

Agència per a la Competitivitat de l'empresa - ACCIÓ

Innovative medical technologies

KTN

Insights into the Canadian eHealth Landscape - MaRS Future of Medicine

MaRS Discovery District

What's hot (20)

EUnetHTA Training course for Stakeholders - Choice of Endpoints forReimburse...

EUnetHTA Training course for Stakeholders - Key principles of Health Technolo...

EUnetHTA Training course for Stakeholders - Brief introduction to EUnetHTA an...

EUnetHTA Training course for Stakeholders - Brief introduction to EUnetHTA

Cadth 2015 d2 warren cadth april_14_2015

1st eStandards conference: next steps for standardization in large scale eHea...

eStandards conference: Next steps for standardization in large scale eHealth ...

Health Technology Assessment : Interpreting a HTA report

Health Technology Assessment (HTA): a tool for evidence-informed decision mak...

1st eStandards conference: next steps for standardization in large scale eHea...

Evaluating Health Technology Assessment Reports and New Assessment Techniques...

Présentation d'Alain Bravo à la journée "Questions numériques 2011"

Governance in DRIVE - Laurence Torcel-Paignon Sanofi Pasteur

Building a Community of Practice for people in charge of HTA dissemination

Connected health data meets the people: Diversity, Standards, and Trust

European study on Monitoring e-accessibility 2009-2011

Commission studies on eaccessibility

Horizon 2020 Proposal evaluation

Innovative medical technologies

Insights into the Canadian eHealth Landscape - MaRS Future of Medicine

Viewers also liked

4 Pillars of High Impact Leadership

Jennifer McClure

Manage Stakeholder Relations

Info-Tech Research Group

ICT in Healthcare

Nawanan Theera-Ampornpunt

The document discusses information and communication technology (ICT) in healthcare. It begins with an introduction to the speaker, Nawanan Theera-Ampornpunt, which includes their background and credentials. The presentation then discusses various aspects of digitizing healthcare, including what constitutes a "smart hospital" compared to just a digital or paperless hospital. Key points are that a smart hospital focuses on using technology and information to improve quality, safety, efficiency and other aspects of patient care. The presentation also covers why healthcare needs ICT, examples of health IT tools, and the importance of standards to enable information exchange and interoperability between different healthcare providers and systems.

Hospital management system

subu

The document outlines a hospital management system project that includes maintaining patient details, prescriptions, tests, and billing. It describes the scope of the project, stakeholders like patients, doctors, and staff. It discusses the feasibility of the system in terms of technical capabilities, scalability, and flexibility. Diagrams show the database, pharmaceutical activities, and remote doctor consultations. The presentation concludes with screenshots of the billing and payment system and thanks the audience.

Project Stakeholder Management - PMBOK 5

pankajsh10

This document discusses project stakeholder management. It provides an overview of identifying stakeholders, planning stakeholder management, and managing stakeholder engagement. Key points covered include identifying stakeholders using tools like stakeholder analysis, developing a stakeholder register output. It also discusses planning stakeholder management, including developing a stakeholder management plan using inputs like the stakeholder register and meetings to define engagement levels.

Hospital Management System

ĞĔŃÚĨŃĔ ĞĔŃĨÚŚ

Hospital Management System

Pranil Dukare

PROJECT-HOSPITAL MANAGEMENT SYSTEM CHAP. 1 TO 4

NICHOLAS RATEMO

This document provides background information on the proposed Nyamache Management System project. It summarizes the current manual patient record keeping system at Nyamache Hospital, which involves paper-based registration, billing, and record retrieval. This is inefficient and error-prone. The proposed electronic system aims to improve accuracy, efficiency and information retrieval. It will involve modules for registration, billing, stock management and administration. The document outlines the project objectives, budget, and methodology using a system development lifecycle approach involving planning, analysis, design, testing and documentation.

Viewers also liked (8)

4 Pillars of High Impact Leadership

Manage Stakeholder Relations

ICT in Healthcare

Hospital management system

Project Stakeholder Management - PMBOK 5

Hospital Management System

PROJECT-HOSPITAL MANAGEMENT SYSTEM CHAP. 1 TO 4

Similar to How can patients and providers best contribute to the HTA process?

${c1708a15-166a-4242-9306-4cbce9f0d948}_4775_18AUG16_PanEuropeanCollaborations$ ${c1708a15-166a-4242-9306-4cbce9f0d948}_4775_18AUG16_PanEuropeanCollaborations$

{c1708a15-166a-4242-9306-4cbce9f0d948}_4775_18AUG16_PanEuropeanCollaborations

Goutam Dutta

The document summarizes the work of EUnetHTA, a European network for Health Technology Assessment. It discusses EUnetHTA's projects from 2005 to the present, focusing on Joint Action 2 from 2012-2015. Key outputs of EUnetHTA include the HTA Core Model for assessment, pilot assessments, an evidence submission template, and recommendations for sustainable HTA cooperation in Europe. EUnetHTA involves collaboration between HTA organizations across European countries and regions to facilitate efficient use of resources and promote knowledge sharing in HTA methods and processes.

First Report on PharmaLedger Workshops and Events

PharmaLedger

The objective of this document is to provide the 1st report of the PharmaLedger Workshops, Events and the key activities engaged in, and achieved, to end of M18. The report focuses on the design and delivery of a series of webinars to support the Co-Creation Workshops which became the only method of achieving the aims of dissemination and communication possible during the global COVID-19 pandemic. The report examines the steps and elements which were factors in the successful delivery of the webinar series including the overall strategy, the format for the webinars, the workflow required to deliver the webinars on time, the method of delivery and the feedback mechanisms put in place to identify improvements and measure impact with audiences.

FRACTALS introduction - Innovative ideas for the farm of the future

Technology Park Ljubljana

Fractals Project Overview

Grigoris Chatzikostas

This document summarizes an event on innovative ideas for agriculture. It discusses the FIWARE project background and phases, as well as the FRACTALS project. FRACTALS aims to provide grants and support to 50-60 SMEs to develop apps for agriculture using FIWARE technologies. It will provide technical support, app validation through an existing user community, and entrepreneurial mentoring. Eligible projects must enhance farm productivity, access markets, or improve public services using FIWARE.

FRACTALS FIWARE Accelerator: Introduction

Grigoris Chatzikostas

This document provides information about the FRACTALS project, which aims to support SMEs and web entrepreneurs in developing innovative applications for the agricultural sector using FI-WARE infrastructure. FRACTALS will run an open call to fund 50-60 sub-projects from SMEs, offering grants of €50,000-€150,000 each. Successful applicants will receive technical support and have their applications validated through a living lab. The open call will launch on November 30th 2014, with a deadline of February 28th 2015 for applications to be evaluated. Eligible projects must integrate FI-WARE technologies and be in areas like enhancing farm productivity, accessing markets, or improving public services.

Closing Remarks - AAL Market Observatory Workshop - 22 May 2014

deboradg

OpenAIRE factsheet: H2020 Open Data Pilot

OpenAIRE

The document discusses the Open Data Pilot in Horizon 2020, which aims to improve access to and reuse of research data generated by projects. Participants will be required to deposit data and enable access for third parties. The creation of Data Management Plans is integral. The pilot applies to projects in specified areas that must deposit research data in repositories and enable third party access and reuse. Costs for implementing open data requirements are eligible.

Livewell Project @ Health Informatics Scotland 2014, Glasgow, 2 Sep 2014

Maged N. Kamel Boulos

Please cite as: Kamel Boulos MN, Livewell Project Consortium. Livewell Project (project overview and early user feedback and impressions from the Summer 2014 pilot testing phase). In: Online Proceedings of Health Informatics Scotland 2014 Conference, Glasgow, Scotland, 2 September 2014. URLs: http://www.webcitation.org/6SIO8Vo19 and http://www.knowledge.scot.nhs.uk/his/events/health-informatics-scotland-conference-2014/presentations-and-audio.aspx http://www.slideshare.net/sl.medic/livewellhis-glasgow2-sep2014

20151029_Infoday H2020 Energía_Mª Luisa Revilla

Redit

The document provides information on the EU's Horizon 2020 program for clean, secure and efficient energy for the 2016-2017 work program. It discusses the political context, budget details, focus areas of energy efficiency, low carbon technologies, and smart cities and communities. Cross-cutting activities and opportunities for SMEs are also outlined. Participation data from the April 2015 call showed 264 proposals submitted, with 16 receiving funding. Common weaknesses identified in proposals included limited innovation value, lack of market analysis, undefined user needs, and unsupported economic impact claims.

Alicia Granados: Adaptive Pathways and Lifecycle Approach (ADAPTSMART

Canadian Organization for Rare Disorders

This document discusses the Medicine Adaptive Pathways to Patients (MAPPs) project. MAPPs uses an adaptive pathways approach, which employs iterative development, real-world data collection, and engagement with multiple stakeholders to help bring new medicines to patients with high unmet medical needs more efficiently. The current process for drug approval and reimbursement has led to misalignment between regulators and health technology assessors, resulting in delays to patient access. MAPPs aims to address this through collaborative evidence generation and guidance along the development pathway.

Horizon 2020 Fast Track to Innovation - Lorraine Martin

Invest Northern Ireland

The document summarizes Dr. Lorraine Martin's presentation on receiving funding from the Horizon 2020 SME Instrument. It discusses ProAxsis' protease-tag technology for detecting disease biomarkers, their roadmap to commercialization including previous funding awards, and their plan to develop a point-of-care test for lung disease through two phases funded by Horizon 2020. It also provides details on applying for funding, the application and review process, requirements for funding agreements, and benefits of participating including publicity and experience with the program.

The EUnetHTA perspective on the HTA database

Patrice Chalon

Presentation at HTAi Annual meeting 2017, panel session "Rescuing the HTA database – future options and challenges" A central, international database for HTA reports and other HTA products is considered to be a vital source of information for healthcare researchers and stakeholders. The current HTA database, which contains over 15,000 documents submitted by numerous HTA agencies, was originally established by the International Network of Agencies for Health Technology Assessment (INAHTA) in 2007 and is available on the website of the UK Centre for Reviews and Dissemination (CRD). The database has so far been funded by the UK National Institute for Health Research (NIHR). Its existence is however endangered as future funding is unclear. If no alternative is found, it will no longer be maintained and only an archived version will be available. There would thus no longer be a single access point to HTA reports. Previous research has indicated that more than 75% of HTA agencies use the HTA database and more than half adapt common HTA products from reports produced by other agencies.1 The lack of an HTA database would have a direct impact on these activities. Smaller HTA agencies would be particularly affected, as they often have insufficient resources to produce their own reports and rely on reports from larger agencies. The wider consequences should also be considered: for instance, the decreasing visibility of HTA reports would diminish their relevance. It may also become more difficult to establish collaborations between HTA agencies. The problem would thus affect the whole HTA community. Often, however, a crisis also offers opportunities. The establishment of a new HTA database should include a re-evaluation of its structure and technical functions (e.g. inclusion of ongoing projects). Structure of the session: Short presentations will be held to provide an overview of the different perspectives of the various HTA agencies and networks currently involved in the discussions on the future of the HTA database. The panel will focus on the initiatives to rescue the database and present the options for funding, hosting, structure and technical functions. There will also be a guided discussion on the possible solutions presented and the challenges faced. Panel/Workshop outcome and objectives: At the end of the session, participants should be aware of the overall importance of the HTA database, the current status quo, and the potential features of a future HTA database.

FINODEX - General presentation on EU public funding

Miguel García González

The document provides an overview of EU public funding opportunities through the Horizon 2020 (H2020) program. H2020 provides over €70 billion between 2014-2020 for research and innovation. It is structured around societal challenges, industrial leadership, and excellent science. Funding is provided through various instruments like Innovation Actions and Research and Innovation Actions. Eligible organizations can receive funding to cover personnel costs, subcontracting, equipment, travel and more. The SME Instrument and Fast Track to Innovation specifically support innovative small businesses through multi-phase programs including feasibility studies and demonstration projects.

From certification to participatory systems: the current landscape

UNI - Ente Italiano di Normazione

OpenCoesione at INFORM meeting

OpenCoesione

This document summarizes the state of open data and transparency for EU structural and investment funds from 2007-2013 and the new requirements for 2014-2020. It discusses how transparency has increased over time, with machine-readable open data now required along with standardized fields like project name, beneficiary, location and finances. A survey found most countries now have centralized websites but quality and details vary, with constraints including IT systems and privacy laws. The document advocates using open fund data for civic monitoring, research, data journalism and other reuses to improve transparency and accountability.

EUnetHTA Joint Action 2 and long term strategy

EUnetHTA

Startup Europe: EU funding for start-ups

Iraklis Agiovlasitis

Do you have the next big commercial idea that will disrupt the ICT industry and conquer the world? Are you looking for money for your start-up, without giving up equity? Do you want to find out what Open Disruptive Innovation, FI-WARE or COSME mean? Compared to traditional investors from the private sector, EU funding provides support with minimal strings attached and does not require Entrepreneurs to surrender any ownership of their idea or shares of their start-up. This presentation was part of the workshops sessions in ID-GC 2014 event held in Athens Concert Hall (15 Novermber 2014).

Hta fhz

EURORDIS Rare Diseases Europe

The document discusses upcoming major changes to health technology assessment (HTA) in Europe. It outlines the three main steps of HTA - determining regulatory approval, assessing effectiveness in clinical practice, and reimbursement/pricing decisions based on the assessment. Key domains assessed include clinical, economic, and patient/social aspects. Stakeholders can engage in early dialogues, scoping assessments, and providing information for assessments. The European network for HTA (EUnetHTA) involves 81 HTA bodies conducting joint assessments to streamline the process across countries. The principles of EUnetHTA include involvement of patients at different stages of HTA.

Towards digital homes for ageing: Evidence-based policy lessons - Stephanie ...

CARER+ Project

SMART4MD Report from User-Centered Design of e-health solution for mild-demen...

Jan Kubalík

Similar to How can patients and providers best contribute to the HTA process? (20)

${c1708a15-166a-4242-9306-4cbce9f0d948}_4775_18AUG16_PanEuropeanCollaborations$ ${c1708a15-166a-4242-9306-4cbce9f0d948}_4775_18AUG16_PanEuropeanCollaborations$

{c1708a15-166a-4242-9306-4cbce9f0d948}_4775_18AUG16_PanEuropeanCollaborations

First Report on PharmaLedger Workshops and Events

FRACTALS introduction - Innovative ideas for the farm of the future

Fractals Project Overview

FRACTALS FIWARE Accelerator: Introduction

Closing Remarks - AAL Market Observatory Workshop - 22 May 2014

OpenAIRE factsheet: H2020 Open Data Pilot

Livewell Project @ Health Informatics Scotland 2014, Glasgow, 2 Sep 2014

20151029_Infoday H2020 Energía_Mª Luisa Revilla

Alicia Granados: Adaptive Pathways and Lifecycle Approach (ADAPTSMART

Horizon 2020 Fast Track to Innovation - Lorraine Martin

The EUnetHTA perspective on the HTA database

FINODEX - General presentation on EU public funding

From certification to participatory systems: the current landscape

OpenCoesione at INFORM meeting

EUnetHTA Joint Action 2 and long term strategy

Startup Europe: EU funding for start-ups

Hta fhz

Towards digital homes for ageing: Evidence-based policy lessons - Stephanie ...

SMART4MD Report from User-Centered Design of e-health solution for mild-demen...

Recently uploaded

Pollen and Fungal allergy: aeroallergy.pdf

Chulalongkorn Allergy and Clinical Immunology Research Group

LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES

ShraddhaTamshettiwar

low birth weight presentation. Low birth weight (LBW) infant is defined as the one whose birth weight is less than 2500g irrespective of their gestational age. Premature birth and low birth weight(LBW) is still a serious problem in newborn. Causing high morbidity and mortality rate worldwide. The nursing care provide to low birth weight babies is crucial in promoting their overall health and development. Through careful assessment, diagnosis,, planning, and evaluation plays a vital role in ensuring these vulnerable infants receive the specialize care they need. In India every third of the infant weight less than 2500g. Birth period, socioeconomical status, nutritional and intrauterine environment are the factors influencing low birth weight

Medical Quiz ( Online Quiz for API Meet 2024 ).pdf

Jim Jacob Roy

Skin Diseases That Happen During Summer.

Gokuldas Hospital

CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf

rishi2789

Travel Clinic Cardiff: Health Advice for International Travelers

NX Healthcare

Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk

8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx

Holistified Wellness

We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.

Pharmacology of 5-hydroxytryptamine and Antagonist

Dr. Nikhilkumar Sakle

5-hydroxytryptamine or 5-HT or Serotonin is a neurotransmitter that serves a range of roles in the human body. It is sometimes referred to as the happy chemical since it promotes overall well-being and happiness. It is mostly found in the brain, intestines, and blood platelets. 5-HT is utilised to transport messages between nerve cells, is known to be involved in smooth muscle contraction, and adds to overall well-being and pleasure, among other benefits. 5-HT regulates the body's sleep-wake cycles and internal clock by acting as a precursor to melatonin. It is hypothesised to regulate hunger, emotions, motor, cognitive, and autonomic processes.

CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf

rishi2789

CBL Seminar 2024_Preliminary Program.pdf

suvadeepdas911

Tele Optometry (kunj'sppt) / Basics of tele optometry.

Kunj Vihari

vonoprazan A novel drug for GERD presentation

Dr.pavithra Anandan

Recent advances on Cervical cancer .pptx

DrGirishJHoogar

How to Control Your Asthma Tips by gokuldas hospital.

Gokuldas Hospital

Know the difference between Endodontics and Orthodontics.

Gokuldas Hospital

Physical demands in sports - WCSPT Oslo 2024

Torstein Dalen-Lorentsen

Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf

MuhammadMuneer49

Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad

NephroTube - Dr.Gawad

- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ - Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0 - Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html - Link to NephroTube website: www.NephroTube.com - Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html

Histololgy of Female Reproductive System.pptx

AyeshaZaid1

Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.

CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf

rishi2789

Recently uploaded (20)

Pollen and Fungal allergy: aeroallergy.pdf

LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES

Medical Quiz ( Online Quiz for API Meet 2024 ).pdf

Skin Diseases That Happen During Summer.

CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf

Travel Clinic Cardiff: Health Advice for International Travelers

8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx

Pharmacology of 5-hydroxytryptamine and Antagonist

CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf

CBL Seminar 2024_Preliminary Program.pdf

Tele Optometry (kunj'sppt) / Basics of tele optometry.

vonoprazan A novel drug for GERD presentation

Recent advances on Cervical cancer .pptx

How to Control Your Asthma Tips by gokuldas hospital.

Know the difference between Endodontics and Orthodontics.

Physical demands in sports - WCSPT Oslo 2024

Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf

Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad

Histololgy of Female Reproductive System.pptx

CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf

How can patients and providers best contribute to the HTA process?

1. European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu How can patients and providers best contribute to the HTA process Sime Warren, National Health Care Institute of the Netherlands, Diemen, the Netherlands Anna Nachtnebel, Ludwig Boltzmann Institute for HTA, Vienna, Austria WP5 - Applying the HTA Core Model for Rapid Assessment for national adaptation and reporting Third WP2 Face to Face Training Course for EUnetHTA stakeholders, Brussels, 23rd of April 2015

2. European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.euEuropean network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu Stakeholder involvement Strand A and Strand B 2

3. Stakeholder Involvement Strand A Close collaboration with the participating manufacturer Update of the HTA Core Model application for REAs  Stakeholder and public consultation Feedback session with manufacturer about the draft submission template (WP7)

4. May 8, 2015European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu 4 Stakeholder Involvement Strand B

5. European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu Compilation of final project plan  Stakeholder Advisory Group & Stakeholder Forum: informed about upcoming public consultation of project plan, inquiry to suggest external medical experts, patients representatives, identification of manufacturers  Manufacturer(s): informed about upcoming public consultation of project plan, to submit evidence/information on reimbursement status, submission file, scoping meeting(?)  Patients: scoping - selection of relevant outcomes, comparators, draft project plan  Medical experts: scoping - selection of relevant outcomes, comparators, draft project plan  Public: draft project plan Stakeholder involvement - Scoping Phase

6. European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu Production of final assessment Manufacturer(s), patients, medical experts: opportunity to comment on second draft of assessment, comments & answers publicly available Further involvement Update of HTA Core Model for Rapid REA Stakeholder involvement - Assessment Phase 6

7. European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu 1. Where do you think stakeholder involvement is most relevant? 2. Could you think of other ways of stakeholder involvement? Plenary session Strand A and Strand B 7

8. European network for Health Technology Assessment | JA2 2012-2015 | www.eunethta.eu Thank you! This presentation arises from the EUnetHTA Joint Action 2 which has received funding from the European Union, in the framework of the Health Programme

Editor's Notes

Title slide yellow
5

How can patients and providers best contribute to the HTA process?

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

Viewers also liked

Viewers also liked (8)

Similar to How can patients and providers best contribute to the HTA process?

Similar to How can patients and providers best contribute to the HTA process? (20)

Recently uploaded

Recently uploaded (20)

How can patients and providers best contribute to the HTA process?

Editor's Notes